Clinical Trial Update: O(6)-Benzylguanine in Treating Patients With Malignant Glioma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of O6-benzylguanine in patients with malignant glioma has completed, with an update on the study status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumors
• Malignant Glioma

Drugs mentioned

• O6-Benzylguanine (O6-Benzylguanine)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: COMPLETED